The Role of Inflammatory Pathways in Implantation Failure: Chronic Endometritis and Hydrosalpinges

Seminars in Reproductive Medicine

Volumn 33, Issue 4, 2015, Pages 298-304

  Akopians, Alin L ^a,b   Pisarska, Margareta D ^a,b   Wang, Erica T ^a,b  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

chronic endometritis; hydrosalpinx; implantation failure

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; BETA3 INTEGRIN; CIPROFLOXACIN; CORTICOSTEROID; DOXYCYCLINE; GELATINASE A; GELATINASE B; IMMUNOGLOBULIN A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 2; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MESSENGER RNA; METRONIDAZOLE;

ARTICLE; BACTERIUM ISOLATION; CORTICOSTEROID THERAPY; CYTOKINE RELEASE; EMBRYO IMPLANTATION FAILURE; ENDOMETRITIS; ENDOMETRIUM BIOPSY; FERTILIZATION IN VITRO; FUNGUS ISOLATION; HISTOPATHOLOGY; HUMAN; HYDROSALPINX; HYSTEROSALPINGOGRAPHY; HYSTEROSCOPY; IMMUNE RESPONSE; LAPAROSCOPIC SURGERY; LAPAROSCOPY; LEUKOCYTE; MENSTRUAL CYCLE; NIDATION; NONHUMAN; PATHOPHYSIOLOGY; PLASMA CELL; PREGNANCY DISORDER; PREGNANCY OUTCOME; PREGNANCY RATE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SALPINGECTOMY; TREATMENT CONTRAINDICATION; TUBAL OCCLUSION INSERT; UTERINE TUBE OCCLUSION; FEMALE; FEMALE INFERTILITY; INFLAMMATION; METABOLISM; PATHOLOGY; PHYSIOLOGY;

EMBRYO IMPLANTATION; ENDOMETRITIS; FEMALE; HUMANS; INFERTILITY, FEMALE; INFLAMMATION;

EID: 84934270542     PISSN: 15268004     EISSN: 15264564     Source Type: Journal    
DOI: 10.1055/s-0035-1554916     Document Type: Article

References (69)

1. Morris H., Edwards J., Tiltman A., Emms M. Endometrial lymphoid tissue: an immunohistological study. J Clin Pathol: 1985; 38 6 644 652
2. Disep B., Innes B. A., Cochrane H. R., Tijani S., Bulmer J. N. Immunohistochemical characterization of endometrial leucocytes in endometritis. Histopathology: 2004; 45 6 625 632
3. Salamonsen L. A., Zhang J., Brasted M. Leukocyte networks and human endometrial remodelling. J Reprod Immunol: 2002; 57 1-2 95 108
4. Inoue T., Kanzaki H., Iwai M., et al. Tumour necrosis factor alpha inhibits in-vitro decidualization of human endometrial stromal cells. Hum Reprod: 1994; 9 12 2411 2417
5. Kariya M., Kanzaki H., Takakura K., et al. Interleukin-1 inhibits in vitro decidualization of human endometrial stromal cells. J Clin Endocrinol Metab: 1991; 73 6 1170 1174
6. Kojima K., Kanzaki H., Iwai M., et al. Expression of leukemia inhibitory factor in human endometrium and placenta. Biol Reprod: 1994; 50 4 882 887
7. Kitaya K., Yasuo T. Aberrant expression of selectin E, CXCL1, and CXCL13 in chronic endometritis. Mod Pathol: 2010; 23 8 1136 1146
8. van Mourik M. S., Macklon N. S., Heijnen C. J. Embryonic implantation: cytokines, adhesion molecules, and immune cells in establishing an implantation environment. J Leukoc Biol: 2009; 85 1 4 19
9. Kämmerer U. Antigen-presenting cells in the decidua. Chem Immunol Allergy: 2005; 89 96 104
10. Hanna J., Goldman-Wohl D., Hamani Y., et al. Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat Med: 2006; 12 9 1065 1074
11. Li R., Hao G. Local injury to the endometrium: its effect on implantation. Curr Opin Obstet Gynecol: 2009; 21 3 236 239
12. Gnainsky Y., Granot I., Aldo P. B., et al. Local injury of the endometrium induces an inflammatory response that promotes successful implantation. Fertil Steril: 2010; 94 6 2030 2036
13. Raziel A., Schachter M., Strassburger D., Bern O., Ron-El R., Friedler S. Favorable influence of local injury to the endometrium in intracytoplasmic sperm injection patients with high-order implantation failure. Fertil Steril: 2007; 87 1 198 201
14. Daware M. B., Mujumdar A. M., Ghaskadbi S. Reproductive toxicity of piperine in Swiss albino mice. Planta Med: 2000; 66 3 231 236
15. Karimzadeh M. A., Ayazi Rozbahani M., Tabibnejad N. Endometrial local injury improves the pregnancy rate among recurrent implantation failure patients undergoing in vitro fertilisation/intra cytoplasmic sperm injection: a randomised clinical trial. Aust N Z J Obstet Gynaecol: 2009; 49 6 677 680
16. Narvekar S. A., Gupta N., Shetty N., Kottur A., Srinivas M., Rao K. A. Does local endometrial injury in the nontransfer cycle improve the IVF-ET outcome in the subsequent cycle in patients with previous unsuccessful IVF? A randomized controlled pilot study. J Hum Reprod Sci: 2010; 3 1 15 19
17. Guven S., Kart C., Unsal M. A., Yildirim O., Odaci E., Yulug E. Endometrial injury may increase the clinical pregnancy rate in normoresponders undergoing long agonist protocol ICSI cycles with single embryo transfer. Eur J Obstet Gynecol Reprod Biol: 2014; 173 58 62
18. Zhou L., Li R., Wang R., Huang H. X., Zhong K. Local injury to the endometrium in controlled ovarian hyperstimulation cycles improves implantation rates. Fertil Steril: 2008; 89 5 1166 1176
19. Potdar N., Gelbaya T., Nardo L. G. Endometrial injury to overcome recurrent embryo implantation failure: a systematic review and meta-analysis. Reprod Biomed Online: 2012; 25 6 561 571
20. Greenwood S. M., Moran J. J. Chronic endometritis: morphologic and clinical observations. Obstet Gynecol: 1981; 58 2 176 184
21. Kasius J. C., Fatemi H. M., Bourgain C., et al. The impact of chronic endometritis on reproductive outcome. Fertil Steril: 2011; 96 6 1451 1456
22. Romero R., Espinoza J., Mazor M. Can endometrial infection/inflammation explain implantation failure, spontaneous abortion, and preterm birth after in vitro fertilization? Fertil Steril: 2004; 82 4 799 804
23. Rinehart J. Recurrent implantation failure: definition. J Assist Reprod Genet: 2007; 24 7 284 287
24. Thornhill A. R., deDie-Smulders C. E., Geraedts J. P., et al. ESHRE PGD Consortium. ESHRE PGD Consortium 'Best practice guidelines for clinical preimplantation genetic diagnosis (PGD) and preimplantation genetic screening (PGS)' Hum Reprod: 2005; 20 1 35 48
25. Cicinelli E., Matteo M., Tinelli R., et al. Prevalence of chronic endometritis in repeated unexplained implantation failure and the IVF success rate after antibiotic therapy. Hum Reprod: 2015; 30 2 323 330
26. Coughlan C., Ledger W., Wang Q., et al. Recurrent implantation failure: definition and management. Reprod Biomed Online: 2014; 28 1 14 38
27. Yang R., Du X., Wang Y., Song X., Yang Y., Qiao J. The hysteroscopy and histological diagnosis and treatment value of chronic endometritis in recurrent implantation failure patients. Arch Gynecol Obstet: 2014; 289 6 1363 1369
28. Cicinelli E., De Ziegler D., Nicoletti R., et al. Chronic endometritis: correlation among hysteroscopic, histologic, and bacteriologic findings in a prospective trial with 2190 consecutive office hysteroscopies. Fertil Steril: 2008; 89 3 677 684
29. Polisseni F., Bambirra E. A., Camargos A. F. Detection of chronic endometritis by diagnostic hysteroscopy in asymptomatic infertile patients. Gynecol Obstet Invest: 2003; 55 4 205 210
30. Matteo M., Cicinelli E., Greco P., et al. Abnormal pattern of lymphocyte subpopulations in the endometrium of infertile women with chronic endometritis. Am J Reprod Immunol: 2009; 61 5 322 329
31. Xu Z., Zan H., Pone E. J., Mai T., Casali P. Immunoglobulin class-switch DNA recombination: induction, targeting and beyond. Nat Rev Immunol: 2012; 12 7 517 531
32. Kitaya K., Tada Y., Hayashi T., Taguchi S., Funabiki M., Nakamura Y. Comprehensive endometrial immunoglobulin subclass analysis in infertile women suffering from repeated implantation failure with or without chronic endometritis. Am J Reprod Immunol: 2014; 72 4 386 391
33. Pitsos M., Kanakas N. The role of matrix metalloproteinases in the pathogenesis of endometriosis. Reprod Sci: 2009; 16 8 717 726
34. Inagaki N., Stern C., McBain J., Lopata A., Kornman L., Wilkinson D. Analysis of intra-uterine cytokine concentration and matrix-metalloproteinase activity in women with recurrent failed embryo transfer. Hum Reprod: 2003; 18 3 608 615
35. Liu G., Zhang X., Lin H., et al. Effects of E-cadherin on mouse embryo implantation and expression of matrix metalloproteinase-2 and -9. Biochem Biophys Res Commun: 2006; 343 3 832 838
36. Yoshii N., Hamatani T., Inagaki N., et al. Successful implantation after reducing matrix metalloproteinase activity in the uterine cavity. Reprod Biol Endocrinol: 2013; 11 37
37. Di Pietro C., Cicinelli E., Guglielmino M. R., et al. Altered transcriptional regulation of cytokines, growth factors, and apoptotic proteins in the endometrium of infertile women with chronic endometritis. Am J Reprod Immunol: 2013; 69 5 509 517
38. Johnston-MacAnanny E. B., Hartnett J., Engmann L. L., Nulsen J. C., Sanders M. M., Benadiva C. A. Chronic endometritis is a frequent finding in women with recurrent implantation failure after in vitro fertilization. Fertil Steril: 2010; 93 2 437 441
39. Savaris R. F., Giudice L. C. The influence of hydrosalpinx on markers of endometrial receptivity. Semin Reprod Med: 2007; 25 6 476 482
40. Bloechle M. What is a hydrosalpinx? A plea for the use of a proper terminology in scientific discussion. Hum Reprod: 1999; 14 3 578
41. de Wit W., Gowrising C. J., Kuik D. J., Lens J. W., Schats R. Only hydrosalpinges visible on ultrasound are associated with reduced implantation and pregnancy rates after in-vitro fertilization. Hum Reprod: 1998; 13 6 1696 1701
42. Renbaum L., Ufberg D., Sammel M., Zhou L., Jabara S., Barnhart K. Reliability of clinicians versus radiologists for detecting abnormalities on hysterosalpingogram films. Fertil Steril: 2002; 78 3 614 618
43. Omurtag K., Grindler N. M., Roehl K. A., et al. How members of the Society for Reproductive Endocrinology and Infertility and Society of Reproductive Surgeons evaluate, define, and manage hydrosalpinges. Fertil Steril: 2012; 97 5 1095 100.e1, 2
44. Zeyneloglu H. B., Arici A., Olive D. L. Adverse effects of hydrosalpinx on pregnancy rates after in vitro fertilization-embryo transfer. Fertil Steril: 1998; 70 3 492 499
45. Camus E., Poncelet C., Goffinet F., et al. Pregnancy rates after in-vitro fertilization in cases of tubal infertility with and without hydrosalpinx: a meta-analysis of published comparative studies. Hum Reprod: 1999; 14 5 1243 1249
46. Mukherjee T., Copperman A. B., McCaffrey C., Cook C. A., Bustillo M., Obasaju M. F. Hydrosalpinx fluid has embryotoxic effects on murine embryogenesis: a case for prophylactic salpingectomy. Fertil Steril: 1996; 66 5 851 853
47. Ng E. H., Chan C. C., Tang O. S., Ho P. C. Comparison of endometrial and subendometrial blood flows among patients with and without hydrosalpinx shown on scanning during in vitro fertilization treatment. Fertil Steril: 2006; 85 2 333 338
48. Meyer W. R., Castelbaum A. J., Somkuti S., et al. Hydrosalpinges adversely affect markers of endometrial receptivity. Hum Reprod: 1997; 12 7 1393 1398
49. Lessey B. A. Endometrial integrins and the establishment of uterine receptivity. Hum Reprod: 1998; 13 03 247 258, discussion 259-261
50. Mansour R. T., Aboulghar M. A., Serour G. I., Riad R. Fluid accumulation of the uterine cavity before embryo transfer: a possible hindrance for implantation. J In Vitro Fert Embryo Transf: 1991; 8 3 157 159
51. Bloechle M., Schreiner T., Lisse K. Recurrence of hydrosalpinges after transvaginal aspiration of tubal fluid in an IVF cycle with development of a serometra. Hum Reprod: 1997; 12 4 703 705
52. Copperman A. B., Wells V., Luna M., Kalir T., Sandler B., Mukherjee T. Presence of hydrosalpinx correlated to endometrial inflammatory response in vivo. Fertil Steril: 2006; 86 4 972 976
53. Hill J. A., Polgar K., Anderson D. J. T-helper 1-type immunity to trophoblast in women with recurrent spontaneous abortion. JAMA: 1995; 273 24 1933 1936
54. Song Y., Wang Q., Huang W., Xiao L., Shen L., Xu W. NF κB expression increases and CFTR and MUC1 expression decreases in the endometrium of infertile patients with hydrosalpinx: a comparative study. Reprod Biol Endocrinol: 2012; 10 86
55. Charnock-Jones D. S., Sharkey A. M., Fenwick P., Smith S. K. Leukaemia inhibitory factor mRNA concentration peaks in human endometrium at the time of implantation and the blastocyst contains mRNA for the receptor at this time. J Reprod Fertil: 1994; 101 2 421 426
56. Seli E., Kayisli U. A., Cakmak H., et al. Removal of hydrosalpinges increases endometrial leukaemia inhibitory factor (LIF) expression at the time of the implantation window. Hum Reprod: 2005; 20 11 3012 3017
57. Bildirici I., Bukulmez O., Ensari A., Yarali H., Gurgan T. A prospective evaluation of the effect of salpingectomy on endometrial receptivity in cases of women with communicating hydrosalpinges. Hum Reprod: 2001; 16 11 2422 2426
58. Lessey B. A., Damjanovich L., Coutifaris C., Castelbaum A., Albelda S. M., Buck C. A. Integrin adhesion molecules in the human endometrium. Correlation with the normal and abnormal menstrual cycle. J Clin Invest: 1992; 90 1 188 195
59. Déchaud H., Daurès J. P., Arnal F., Humeau C., Hédon B. Does previous salpingectomy improve implantation and pregnancy rates in patients with severe tubal factor infertility who are undergoing in vitro fertilization? A pilot prospective randomized study. Fertil Steril: 1998; 69 6 1020 1025
60. Strandell A., Lindhard A., Waldenström U., Thorburn J., Janson P. O., Hamberger L. Hydrosalpinx and IVF outcome: a prospective, randomized multicentre trial in Scandinavia on salpingectomy prior to IVF. Hum Reprod: 1999; 14 11 2762 2769
61. Kontoravdis A., Makrakis E., Pantos K., Botsis D., Deligeoroglou E., Creatsas G. Proximal tubal occlusion and salpingectomy result in similar improvement in in vitro fertilization outcome in patients with hydrosalpinx. Fertil Steril: 2006; 86 6 1642 1649
62. Practice Committee of American Society for Reproductive Medicine in collaboration with Society of Reproductive Surgeons Salpingectomy for hydrosalpinx prior to in vitro fertilization. Fertil Steril: 2008; 90 (5, Suppl): S66 S68
63. Zhang Y., Sun Y., Guo Y., Li T. C., Duan H. Salpingectomy and proximal tubal occlusion for hydrosalpinx prior to in vitro fertilization: a meta-analysis of randomized controlled trials. Obstet Gynecol Surv: 2015; 70 1 33 38
64. Rosenfield R. B., Stones R. E., Coates A., Matteri R. K., Hesla J. S. Proximal occlusion of hydrosalpinx by hysteroscopic placement of microinsert before in vitro fertilization-embryo transfer. Fertil Steril: 2005; 83 5 1547 1550
65. Matorras R., Rabanal A., Prieto B., et al. Hysteroscopic hydrosalpinx occlusion with Essure device in IVF patients when salpingectomy or laparoscopy is contraindicated. Eur J Obstet Gynecol Reprod Biol: 2013; 169 1 54 59
66. Hitkari J. A., Singh S. S., Shapiro H. M., Leyland N. Essure treatment of hydrosalpinges. Fertil Steril: 2007; 88 6 1663 1666
67. Sowter M. C., Akande V. A., Williams J. A., Hull M. G. Is the outcome of in-vitro fertilization and embryo transfer treatment improved by spontaneous or surgical drainage of a hydrosalpinx? Hum Reprod: 1997; 12 10 2147 2150
68. Hammadieh N., Coomarasamy A., Ola B., Papaioannou S., Afnan M., Sharif K. Ultrasound-guided hydrosalpinx aspiration during oocyte collection improves pregnancy outcome in IVF: a randomized controlled trial. Hum Reprod: 2008; 23 5 1113 1117
69. Fatemi H. M., Popovic-Todorovic B., Ameryckx L., Bourgain C., Fauser B., Devroey P. In vitro fertilization pregnancy in a patient with proven chronic endometritis. Fertil Steril: 2009; 91 4 1293.e9 1293.e11